[19] [20] Reduced caloric intake , while intended for weight loss, can sometimes lead to insufficient energy consumption, particularly if patients are not eating nutrient-dense foods
The evidence base for the proposed use and its limitations: primarily preclinical, or limited human studies not conducted under Western regulatory standards
RSL3, a ferroptosis inducer, directly acts on GPX4 and inhibits its activity, thus reducing the antioxidant capacity of cells and accumulating ROS, leading to ferroptosis 12
NICE guidance recommends initial treatment with hydroxocobalamin 1mg intramuscularly three times weekly for two weeks, followed by maintenance therapy
Li L, Li T, Qu X, Sun G, Fu Q, Han G